These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22734708)

  • 1. Structure- and ligand-based structure-activity relationships for a series of inhibitors of aldolase.
    Ferreira LG; Andricopulo AD
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):309-16. PubMed ID: 22734708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors.
    Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD
    Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits.
    Martinez-Mayorga K; Byler KG; Ramirez-Hernandez AI; Terrazas-Alvares DE
    Drug Discov Today; 2015 Jul; 20(7):890-8. PubMed ID: 25697479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases.
    Perie J; Riviere-Alric I; Blonski C; Gefflaut T; Lauth de Viguerie N; Trinquier M; Willson M; Opperdoes FR; Callens M
    Pharmacol Ther; 1993 Nov; 60(2):347-65. PubMed ID: 8022865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rational Design, Synthesis, Biological Evaluation and Structure--Activity Relationship Study of Novel Inhibitors against Cyanobacterial Fructose-1,6-bisphosphate Aldolase.
    Han X; Zhu X; Zhu S; Wei L; Hong Z; Guo L; Chen H; Chi B; Liu Y; Feng L; Ren Y; Wan J
    J Chem Inf Model; 2016 Jan; 56(1):73-81. PubMed ID: 26669534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei.
    Dax C; Duffieux F; Chabot N; Coincon M; Sygusch J; Michels PA; Blonski C
    J Med Chem; 2006 Mar; 49(5):1499-502. PubMed ID: 16509566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Drug Discovery for Neglected Diseases.
    Andricopulo AD; Ferreira LLG
    Curr Top Med Chem; 2018; 18(5):313-314. PubMed ID: 29968533
    [No Abstract]   [Full Text] [Related]  

  • 8. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
    Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl ureas represent a new class of anti-trypanosomal agents.
    Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
    Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
    Ferreira LG; Andricopulo AD
    Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization, kinetics, and crystal structures of fructose-1,6-bisphosphate aldolase from the human parasite, Giardia lamblia.
    Galkin A; Kulakova L; Melamud E; Li L; Wu C; Mariano P; Dunaway-Mariano D; Nash TE; Herzberg O
    J Biol Chem; 2007 Feb; 282(7):4859-4867. PubMed ID: 17166851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
    Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
    Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.
    Cáceres AJ; Michels PA; Hannaert V
    Mol Biochem Parasitol; 2010 Jan; 169(1):50-4. PubMed ID: 19748525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.